05:39 PM EDT, 09/09/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said late Tuesday it plans a public offering of common shares.
The company intends to grant underwriters a 30-day overallotment option to buy up to an additional 15% of the shares.
The company said it plans to use net proceeds for general corporate purposes.
Shares of Actuate Therapeutics ( ACTU ) were down more than 16% in after-hours trading.